Grifols presents XEMBIFY (immune globulin subcutaneous human-klhw), a 20% subcutaneous immunoglobulin (IG) for the treatment of primary immunodeficiency diseases. With maximum immunoglobulin G (IgG) potency and purity due to the unique caprylate/chromatography process, XEMBIFY provides a customizable IG treatment option (from weekly to daily) to offer protection from infections.
Enter our Sweepstakes now for your chance to win the following prizes:
Just answer the following quick question for your chance to win:
Entries are limited to one entry per person in any active sweepstakes.
Thank you for your entry.